Guideline for Evaluation and Management of Sulfurous (Rotten‑Egg) Belching

Primary Etiology

Small intestinal bacterial overgrowth (SIBO) is the leading cause of sulfur‑smelling belches, because hydrogen sulfide‑producing bacteria generate the characteristic rotten‑egg odor. 1
Carbohydrate enzyme deficiencies (e.g., lactase, sucrase) and consumption of artificial sweeteners (e.g., sorbitol) promote bacterial fermentation that produces sulfur compounds, leading to foul‑smelling belches. 3
Up to 60 % of patients with disorders of gut‑brain interaction have fructose intolerance and about 51 % have lactose intolerance, both of which can contribute to sulfurous belching. 3
Gastroesophageal reflux disease (GERD) co‑exists in roughly 50 % of individuals with excessive belching and can augment sulfur odor when combined with bacterial overgrowth. 4

Assess for constipation, which suggests IBS‑C or chronic constipation as a predisposing factor for bacterial overgrowth. 1
Identify SIBO risk factors such as prior abdominal surgery, chronic pancreatitis, diabetes, scleroderma, or chronic proton‑pump inhibitor (PPI) use. 1
Screen for alarm features (weight loss > 10 %, gastrointestinal bleeding, persistent vomiting, or family history of inflammatory bowel disease) that mandate urgent evaluation. 1

Begin with a 2‑week elimination diet restricting lactose, fructose, and artificial sweeteners; this is more cost‑effective than immediate testing. 3
If symptoms persist after dietary restriction, perform a hydrogen breath test using glucose or lactulose, measuring hydrogen, methane, and CO₂ to detect SIBO. 1
Small‑bowel aspirate culture provides a definitive SIBO diagnosis but is invasive and reserved for selected cases. 1
Basic laboratory work (CBC, CMP) and imaging (plain abdominal X‑ray or ultrasound) should be obtained when symptoms are refractory to identify structural abnormalities. 1
High‑resolution esophageal manometry with impedance can differentiate gastric from supragastric belching when the pattern is unclear. 4

Rifaximin is the most extensively studied antibiotic for SIBO; however, it is not FDA‑approved for this indication and is costly. 1
Alternative agents (amoxicillin, fluoroquinolones, metronidazole) may be used selectively, with attention to resistance risk. 1
Antibiotic therapy should be limited to patients with confirmed SIBO to avoid unnecessary exposure and resistance development. 1

Sustained dietary avoidance of offending carbohydrates remains the cornerstone of therapy. 3
Lactase enzyme supplementation can alleviate symptoms in lactose‑intolerant individuals. 1
A low‑FODMAP diet is recommended for patients with IBS‑related fructose/fructan sensitivity. 3

Initiate proton‑pump inhibitor therapy together with lifestyle modifications when GERD contributes to belching. 3
Consider baclofen for patients with documented excessive transient lower esophageal sphincter relaxations. 3

Do not dismiss sulfurous belching as benign; the odor specifically points to bacterial fermentation and warrants targeted evaluation. 1
Avoid empiric antibiotics without confirmed SIBO, as this promotes antimicrobial resistance and lacks evidence support. 1
Do not overlook gastroparesis in patients presenting with nausea/vomiting alongside sulfurous belching; motility studies may be required. 3
While anxiety can worsen belching frequency, it does not typically cause the sulfur odor, which indicates a metabolic or bacterial origin. 4